FDA Warning Letter — Chinese Peptide Company
The FDA took a Warning Letter action against Chinese Peptide Company on May 21, 2012 (Hangzhou, China). The action was issued by CDER and concerns drugs products. This facility has 4 recent FDA inspections on record.
Action Details
- Facility
- Chinese Peptide Company
- Date
- May 21, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Center
- CDER
- Location
- Hangzhou (China)